References
- 1. Aguirre A, Nugent CA. Oral Manifestation of Crohn’s Disease. New England Journal of Medicine. 2015;373(13):1250.10.1056/NEJMicm1413715
- 2. Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in wisconsin: a statewide population-based study. The Journal of Pediatrics. 2003;143(4):525-31.10.1067/S0022-3476(03)00444-X
- 3. Bousvaros A, Antonioli D, Colletti R, Dubinsky M, Glickman J, Gold B, et al. Differentiating Ulcerative Colitis from Crohn Disease in Children and Young Adults: Report of a Working Group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohnʼs and Colitis Foundation of America. Journal of pediatric gastroenterology and nutrition. 2007;44:653-74.10.1097/MPG.0b013e31805563f3
- 4. Rosen MJ, Dhawan A, Saeed SA. Inflammatory Bowel Disease in Children and Adolescents. JAMA Pediatrics. 2015;169(11):1053-60.10.1001/jamapediatrics.2015.1982
- 5. Levine A, Wine E, Assa A, Sigall Boneh R, Shaoul R, Kori M, et al. Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterology. 2019;157(2):440-50.e8..10.1053/j.gastro.2019.04.021
- 6. Hindorf U, Lindqvist M, Hildebrand H, Fagerberg U, Almer S. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2006;24(2):331-42.10.1111/j.1365-2036.2006.02977.x
- 7. Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. Journal of Crohn’s and Colitis. 2014;8(10):1179-207.10.1016/j.crohns.2014.04.005